ArticleCatalysis science & technology2025
C(sp
Article in Catalysis science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Nickel-catalyzed cross-coupling reactions are among the most powerful tools in organic synthesis owing to the low cost, natural abundance and high activity of versatile nickel catalysts. However, there is a scarcity of efficient Ni-catalyzed systems for the cross-coupling of bench-stable, readily accessible and orthogonal C-O electrophiles. Herein, we report the cross-coupling of aryl sulfamates enabled by sterically-demanding and electron-rich N-heterocyclic carbenes. The study identified sulfamates as the most reactive C-O electrophiles enabled by a combination of IPr*
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.